Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:629217rdf:typepubmed:Citationlld:pubmed
pubmed-article:629217lifeskim:mentionsumls-concept:C0003402lld:lifeskim
pubmed-article:629217lifeskim:mentionsumls-concept:C0007097lld:lifeskim
pubmed-article:629217lifeskim:mentionsumls-concept:C0003962lld:lifeskim
pubmed-article:629217lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:629217lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:629217pubmed:issue3lld:pubmed
pubmed-article:629217pubmed:dateCreated1978-4-26lld:pubmed
pubmed-article:629217pubmed:abstractTextThe effect of Ehrlich ascites tumor growth on selenium-turnover rates and selenium-75 distribution in liver, kidney, and immunological tissues (spleen, thymus, and lymph nodes) was investigated in Swiss Webster mice that had been prelabeled with selenium-75. Ehrlich ascites tumor caused a decrease in the selenium-75 content of liver, kidney, and thymus; it also decreased the rate of the total-body selenium-turnover. In liver, depletion of selenium-75 was almost as great as that produced by a selenium and vitamin E-deficient diet. When mice had been fed an antioxidant-deficient diet, considerable quantities of selenium-75 were accumulated by the tumor; the specific activity of the tumor increased 9-fold over that in antioxidant-supplemented mice. The same diet produced a premature, and in some cases drastic, contraction in tumor volume. The possible significance of tumor-induced antioxidant deficiencies to the etiology of certain paraneoplastic syndromes is discussed.lld:pubmed
pubmed-article:629217pubmed:languageenglld:pubmed
pubmed-article:629217pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:629217pubmed:citationSubsetAIMlld:pubmed
pubmed-article:629217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:629217pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:629217pubmed:statusMEDLINElld:pubmed
pubmed-article:629217pubmed:monthMarlld:pubmed
pubmed-article:629217pubmed:issn0002-9165lld:pubmed
pubmed-article:629217pubmed:authorpubmed-author:WrightE TETlld:pubmed
pubmed-article:629217pubmed:authorpubmed-author:KAHNJJlld:pubmed
pubmed-article:629217pubmed:authorpubmed-author:BaumgartnerW...lld:pubmed
pubmed-article:629217pubmed:issnTypePrintlld:pubmed
pubmed-article:629217pubmed:volume31lld:pubmed
pubmed-article:629217pubmed:ownerNLMlld:pubmed
pubmed-article:629217pubmed:authorsCompleteYlld:pubmed
pubmed-article:629217pubmed:pagination457-65lld:pubmed
pubmed-article:629217pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-A...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-M...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-K...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-S...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-C...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-L...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-S...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-V...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-A...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-C...lld:pubmed
pubmed-article:629217pubmed:meshHeadingpubmed-meshheading:629217-O...lld:pubmed
pubmed-article:629217pubmed:year1978lld:pubmed
pubmed-article:629217pubmed:articleTitleAntioxidant effects in the development of Ehrlich ascites carcinoma.lld:pubmed
pubmed-article:629217pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:629217pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:629217pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:629217lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:629217lld:pubmed